Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
3 Arrested for $16K GLP-1 Drug Robbery at Pharmacy - Featured image
GLP-1 Medications

3 Arrested for $16K GLP-1 Drug Robbery at Pharmacy

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 19, 2026·1 min read

On this page

  • Details of the Robbery
  • Swift Police Response and Arrests
  • Pre-Robbery Suspicious Activity
  • Charges Filed

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Three suspects face robbery charges after stealing $16,000 worth of GLP-1 weight loss drugs, including Ozempic, Mounjaro, and Trulicity, from a pharmacy delivery in Bensalem, Pennsylvania. Police quickly apprehended the men from New York following a high-speed chase. The incident highlights surging demand for these popular medications.

Share

On this page

  • Details of the Robbery
  • Swift Police Response and Arrests
  • Pre-Robbery Suspicious Activity
  • Charges Filed

Three men were arrested after allegedly assaulting a delivery driver and stealing a shipment of GLP-1 weight loss drugs valued at $16,000 outside a Pennsylvania pharmacy, according to Bensalem Police.

Details of the Robbery

The suspects drove from New York to the Philadelphia suburb of Bensalem. They attacked the driver during a delivery at Smart Choice Pharmacy and fled with boxes of Mounjaro, Ozempic, and Trulicity.

Police reported the men escaped in a gold-colored Toyota, nearly striking a witness attempting to record the incident.

Swift Police Response and Arrests

Officers spotted the Toyota nearby and pulled it over. The vehicle contained 41-year-old Joshua Dupree, 21-year-old Jahnoi Dawkins, and a 17-year-old male, all identified by the driver as the suspects.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

A search of the car recovered the stolen GLP-1 medications.

Pre-Robbery Suspicious Activity

Pharmacy staff noted suspicious phone calls and emails inquiring about the delivery in the days prior. Officials confirmed the trio traveled from New York to execute the robbery.

Charges Filed

  • Robbery
  • Theft
  • Simple assault

The arrests underscore the intense demand for GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) used in weight management.

Source Information

Originally published by NBC Boston.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Beyond the Scale: GLP-1 Users & the Exercise Paradox
Health & Wellness

Beyond the Scale: GLP-1 Users & the Exercise Paradox

While GLP-1 medications have revolutionized weight loss, a recent study indicates a concerning trend: users may be reducing their physical activity. This article explores the findings and emphasizes the continued importance of exercise.

7 min read
Ozempic, Wegovy & Mounjaro: Navigating Dizziness and Fainting Risks
Health & Wellness

Ozempic, Wegovy & Mounjaro: Navigating Dizziness and Fainting Risks

Recent research highlights a potential safety concern with GLP-1 medications, linking them to an increased risk of dizziness and fainting, particularly in certain patient groups. Discover what this means for your health.

6 min read
GLP-1 Revolution in India: Affordability Meets Accessibility in Obesity Fight
Health Technology & Access

GLP-1 Revolution in India: Affordability Meets Accessibility in Obesity Fight

The advent of affordable, locally produced GLP-1 agonists in India marks a significant shift in managing the nation's escalating obesity crisis. For millions like Manoj, these once exclusive medications are now within reach, provided they adhere to strict medical guidance and lifestyle adjustments.

6 min read

Same topic: GLP-1

All GLP-1 articles →
New Obesity Pills in the UAE: Navigating Insurance Coverage for Wegovy and Foundayo
Metabolic Health

New Obesity Pills in the UAE: Navigating Insurance Coverage for Wegovy and Foundayo

As new weight-loss medications enter the UAE market, patients are questioning insurance coverage. We break down the realities of policy, medical necessity, and the future of metabolic health.

2 min read
Medicare Expands GLP-1 Coverage: What the 2027 Policy Shift Means for Seniors
Healthcare Policy

Medicare Expands GLP-1 Coverage: What the 2027 Policy Shift Means for Seniors

The federal government has extended its commitment to fund GLP-1 obesity medications through 2027, shifting away from private insurer mandates to protect seniors from premium hikes.

2 min read
Tirzepatide vs. Semaglutide: A Comprehensive Guide to Cost and Health Outcomes
Medical Research

Tirzepatide vs. Semaglutide: A Comprehensive Guide to Cost and Health Outcomes

A new lifetime economic analysis suggests tirzepatide may offer superior long-term value and clinical outcomes compared to semaglutide for obesity management.

2 min read

More in GLP-1 Medications

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read
Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds
Health & Wellness

Wegovy, Ozempic & Mounjaro: The Real Truth About Weight Loss Meds

A comprehensive guide to GLP-1 receptor agonists, understanding efficacy, managing side effects, and navigating the future of obesity treatment.

7 min read
Share this article
  1. Home
  2. Blog
  3. 3 Arrested for $16K GLP-1 Drug Robbery at Pharmacy
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community